BD BBL Trypticase Soy Agar with 5% Sheep Blood — Class II medical device recall Z-0528-2019
Terminated recall by Becton Dickinson & Co., reported 2018-12-12, distributed nationwide. a portion of a single lot was not manufactured in accordance with the internal formulation resulting in inhibi
| Recall number | Z-0528-2019 |
|---|---|
| Product type | Medical device |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Becton Dickinson & Co., Sparks, MD, United States |
| Recall initiated | 2018-10-22 |
| Classified | 2018-11-30 |
| Reported by FDA | 2018-12-12 |
| Terminated | 2020-04-03 |
| Distributed | Nationwide (US) |
| Quantity | 54,300 plates |
| UPC / GTIN / UDI-DI | 10382902212611 |
| Lot numbers | 8221508 |
| Model numbers | 221261 |
| Expiration dates | 2018-11-30 |
Product
BD BBL Trypticase Soy Agar with 5% Sheep Blood, Catalog No. 221261, (non-selective, non-differential)
Reason for recall
a portion of a single lot was not manufactured in accordance with the internal formulation resulting in inhibited growth of Gram negative organisms.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-0528-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.